Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Life sciences-focused search firm Slone Partners has added esteemed educator Candace Nortey as executive director of diversity, equity and inclusion. In this newly created role, she will help expand the firm’s diversity efforts to enhance opportunities for minority candidates, both internally and for the company’s client partners. “Candace Nortey is an extremely accomplished leader in her field and brings
Sumitovant Biopharma executive Mary Stutts has joined the advisory board of executive search firm Slone Partners. Ms. Stutts is a renowned C-level global branding and growth expert who has provided strategic counsel in the biotechnology, healthcare, technology, and media industries at Fortune 200 companies including Genentech, Bayer, Bristol Myers Squibb, Kaiser Permanente, UnitedHealth Group, and Comcast
Executive search firm Slone Partners has recruited Ingo Chakravarty as the new president and CEO of Mesa Biotech. He assumes leadership of the company less than two months after it received emergency use authorization from the Federal Drug Administration to market its 30-minute point-of-care molecular SARS-CoV-2 test. Mr. Chakravarty succeeds Dr. Hong Cai, co-founder and CEO of Mesa Biotech since
Executive search firm Slone Partners has placed Roger D. Klein as chief medical officer of OmniSeq. Dr. Klein will support OmniSeq in its continued development of innovative products that help oncologists identify the best precision medicine options for their patients. “Dr. Klein is a highly accomplished leader in the innovative fields of molecular pathology, oncology and precision medicine,” said
New board members bring more than 45 years of combined pharmaceutical industry experience SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placements of Stacy R. Lindborg and Christine Pellizzari on the Board of Directors at Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines. Dr. Lindborg
SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Susan Landis as Executive Director of the Association of Clinical Research Professionals’ (ACRP) Board of Trustees. She will begin serving in her new role effective June 14, 2021. Landis brings to ACRP more than 25 years of
(June 2, 2021) Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Susan Landis as Executive Director of the Association of Clinical Research Professionals’ (ACRP) Board of Trustees. She will begin serving in her new role effective June 14, 2021. Landis brings to ACRP more
(April 29, 2021) Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer (CSO) at Enveda Biosciences. In his new role, Dr. Karathanasis will lead the company’s small molecule drug discovery portfolio and work with Enveda’s preclinical
BOSTON, MA, April 12, 2019 – Slone Partners, North America’s leading executive search firm for life sciences and diagnostics companies, announces the placement of Amol Chaubal at Quanterix Corporation as Chief Financial Officer. Responsible for the strategic and tactical financial health of Quanterix as the precision medicine company executes rapid scaling, Mr. Chaubal will report to
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025